BMO Capital Upgrades Edwards Lifesciences To Outperform

BMO Capital upgraded Edwards Lifesciences Corp EW from Market Perform to Outperform. Edwards Lifesciences shares have gained 64.68 percent over the past 52 weeks, while the S&P 500 index has surged 6.59 percent in the same period. Edwards Lifesciences' shares rose 0.01 percent to close at $132.91 yesterday.